TrialBMC neurology2023

Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.

Shengyuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.